Search Medical Condition
Please enter condition
Please choose location from dropdown

Autism Clinical Trials

A listing of Autism medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (236) clinical trials

The purpose of this research study is to learn more about brain development in infants who are at high risk for developing autism. This study will take 3 years to complete. There are four visits with each visit lasting an average of three days for a couple of hours each ...

Phase N/A

Using Mobile Technology to Reduce Stereotypy

Nearly all children with autism spectrum disorders engage in non-functional repetitive vocal and motor behaviours commonly referred to as stereotypy. These repetitive behaviours may considerably interfere with the child's daily functioning, learning, and social inclusion. As such, stereotypy generally has a negative impact on the child and family's health and ...

Phase N/A

Comparing Behavioral Assessments Using Telehealth for Children With Autism

Managing challenging behavior in autism spectrum disorders (ASD) can profoundly improve quality of life for children and families. However, many families lack access to research-based treatment, such as applied behavior analysis (ABA). This study is a randomized trial comparing outcomes of treatment for ASD using either a standard Functional Analysis ...

Phase N/A

Training Attention and Eye Movement in ASD

Autism Spectrum Disorder (ASD) is a lifelong disorder that severely affects the ability to learn and function in a social environment. In typical function, higher level social, language and communication skills develop over the first few years of life and depend upon the critical building blocks of sensory-motor and attention ...

Phase N/A

Pediatric Patients With Metabolic or Other Genetic Disorders

The aim of this protocol is to allow genetic-related evaluations for patients with a variety of known or suspected genetic disorders, supplement and offer an additional opportunity for training in clinical genetics, dysmorphology and metabolic genetics in the National Institute of Child Health and Human Development (NICHD) and other Institutes ...

Phase N/A

Treatment of Disruptive Behaviors in Fragile X Syndrome

Disruptive behaviors such as self-injury, aggression, and property destruction pose significant health-related issues to children diagnosed with fragile X syndrome (FXS), impacting the child's quality of life and causing significant distress to families. Access to appropriate treatment for families is severely limited by factors such as cost of care, shortages ...

Phase N/A

Pilot Study to Improve Access to Early Intervention for Autism in Africa

In this proposal, the investigator's aim is to adapt the caregiver coaching version of the Early Start Denver Model (P-ESDM) and conduct a pilot study to explore the impact of this adapted intervention on child and caregiver outcomes in an African setting as well as understand key facilitators and barriers ...

Phase N/A

Biobanking of Rett Syndrome and Related Disorders

At the present time, effective treatments for RTT, MECP2 Dup, or Rett-related disorders are lacking. Investigators have made substantial progress in RTT over the past eleven years such that this study represents a narrowing of focus to mutations or duplications of the MECP2 gene and related disorders, including those with ...

Phase N/A

Group Social ABCs: Early Intervention for Toddlers With Suspected ASD

The Social ABCs intervention was developed to meet the need for evidence-based, feasible, and sustainable interventions for toddlers with emerging ASD. Unlike other more comprehensive programs, the Social ABCs selectively targets only two key developmental areas (i.e., functional spoken language and positive affect). These domains were selected in order to ...

Phase N/A

Evaluation of the Efficacy Safety and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms

This is a randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, and efficacy of multiple doses of sarizotan in patients with Rett syndrome with respiratory abnormalities. The study participants will be randomized to either sarizotan between 2 and 10 mg bid or placebo bid, based on age and ...

Phase